Page 5 of 6 · 141 questions tagged kidney-function.
What I am working with: magnesium · TSH · orforglipron. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Concretely: LDL-C · eight weeks · survodutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
Conditions: eGFR · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work matters.…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I would like help reading this properly rather than being told…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
The particulars: eGFR · six weeks · oral semaglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the…
Concretely: lipase · two weeks · ecnoglutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have photographed…
Conditions: HbA1c · eGFR · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Concretely: cystatin C · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
Concretely: HbA1c · twelve weeks · retatrutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is not behaving the way I expected and I want to understand the…
Details up front: creatinine · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
What I am working with: ApoB · ferritin · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Setup, so nobody has to ask: cystatin C · three weeks · cagrilintide. An unexpected observation, and I would like a differential rather than reassurance. The…
Details up front: cystatin C · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I would like help reading this properly rather than being…
What I am working with: cystatin C · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
What I am working with: creatinine · a GLP-1 receptor agonist. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
For reference: eGFR · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Setup, so nobody has to ask: albumin-to-creatinine ratio · sixteen weeks · oral semaglutide. I have a result I cannot explain, and I would rather diagnose it than…
Concretely: albumin-to-creatinine ratio · retatrutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…